These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 39153211)
1. Ophiopogonin D' inhibited tumour growth and metastasis of anaplastic thyroid cancer by modulating JUN/RGS4 signalling. Xu T; Zhang W; Zhang Y; Song F; Huang P J Cell Mol Med; 2024 Aug; 28(16):e70014. PubMed ID: 39153211 [TBL] [Abstract][Full Text] [Related]
2. Role of Krüppel-Like Factor 4 in the Maintenance of Chemoresistance of Anaplastic Thyroid Cancer. Lee SI; Kim DK; Seo EJ; Choi EJ; Kwon YW; Jang IH; Lee JC; Kim HY; Shong M; Kim JH; Kim SJ Thyroid; 2017 Nov; 27(11):1424-1432. PubMed ID: 28920531 [TBL] [Abstract][Full Text] [Related]
3. KLF5 influences cell biological function and chemotherapy sensitivity through the JNK signaling pathway in anaplastic thyroid carcinoma. Wang Z; Qiu X; Zhang H; Li W J Biochem Mol Toxicol; 2020 May; 34(5):e22469. PubMed ID: 32173973 [TBL] [Abstract][Full Text] [Related]
4. Torin2 targets dysregulated pathways in anaplastic thyroid cancer and inhibits tumor growth and metastasis. Sadowski SM; Boufraqech M; Zhang L; Mehta A; Kapur P; Zhang Y; Li Z; Shen M; Kebebew E Oncotarget; 2015 Jul; 6(20):18038-49. PubMed ID: 25945839 [TBL] [Abstract][Full Text] [Related]
5. [Ophiopogonin D protects cardiomyocytes against ophiopogonin D'-induced injury through suppressing endoplasmic reticulum stress]. Wang J; Wang NN; Ge YX; Tan HL; Ma ZC; Wang YG; Gao Y Zhongguo Zhong Yao Za Zhi; 2019 May; 44(9):1876-1881. PubMed ID: 31342716 [TBL] [Abstract][Full Text] [Related]
6. CRSP8 promotes thyroid cancer progression by antagonizing IKKα-induced cell differentiation. Liao Y; Hua Y; Li Y; Zhang C; Yu W; Guo P; Zou K; Li W; Sun Y; Wang R; Zuo Y; Sui S; Tian C; Hao J; Chen M; Hu S; Chen M; Long Q; Wang X; Zou L; Xie F; Guo W; Deng W Cell Death Differ; 2021 Apr; 28(4):1347-1363. PubMed ID: 33162555 [TBL] [Abstract][Full Text] [Related]
7. Ophiopogonin D' induces RIPK1‑dependent necroptosis in androgen‑dependent LNCaP prostate cancer cells. Lu Z; Wu C; Zhu M; Song W; Wang H; Wang J; Guo J; Li N; Liu J; Li Y; Xu H Int J Oncol; 2020 Feb; 56(2):439-447. PubMed ID: 31894265 [TBL] [Abstract][Full Text] [Related]
8. Ophiopogonin D'-induced mitophagy and mitochondrial damage are associated with dysregulation of the PINK1/Parkin signaling pathway in AC16 cells. Lei S; Feng Y; Huang P; Chen B; Bao K; Wu Q; Zhang H; Huang X Toxicology; 2022 Jul; 477():153275. PubMed ID: 35905946 [TBL] [Abstract][Full Text] [Related]
9. Potentiated anti-tumor effects of BETi by MEKi in anaplastic thyroid cancer. Zhu X; Park S; Lee WK; Cheng SY Endocr Relat Cancer; 2019 Sep; 26(9):739-750. PubMed ID: 31272080 [TBL] [Abstract][Full Text] [Related]
10. Resveratrol induces differentiation markers expression in anaplastic thyroid carcinoma via activation of Notch1 signaling and suppresses cell growth. Yu XM; Jaskula-Sztul R; Ahmed K; Harrison AD; Kunnimalaiyaan M; Chen H Mol Cancer Ther; 2013 Jul; 12(7):1276-87. PubMed ID: 23594881 [TBL] [Abstract][Full Text] [Related]
11. Ym155 Induces Oxidative Stress-Mediated DNA Damage and Cell Cycle Arrest, and Causes Programmed Cell Death in Anaplastic Thyroid Cancer Cells. Xu Q; Mackay RP; Xiao AY; Copland JA; Weinberger PM Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669447 [TBL] [Abstract][Full Text] [Related]
12. C5AR1-induced TLR1/2 pathway activation drives proliferation and metastasis in anaplastic thyroid cancer. Liu B; Sun Y; Geng T; Wang H; Wu Z; Xu L; Zhang M; Niu X; Zhao C; Shang J; Shang F Mol Carcinog; 2024 Oct; 63(10):1938-1952. PubMed ID: 38934768 [TBL] [Abstract][Full Text] [Related]
13. LncRNA NEAT1 enhances the resistance of anaplastic thyroid carcinoma cells to cisplatin by sponging miR‑9‑5p and regulating SPAG9 expression. Yan P; Su Z; Zhang Z; Gao T Int J Oncol; 2019 Nov; 55(5):988-1002. PubMed ID: 31485599 [TBL] [Abstract][Full Text] [Related]
14. PP121, a dual inhibitor of tyrosine and phosphoinositide kinases, inhibits anaplastic thyroid carcinoma cell proliferation and migration. Che HY; Guo HY; Si XW; You QY; Lou WY Tumour Biol; 2014 Sep; 35(9):8659-64. PubMed ID: 24867098 [TBL] [Abstract][Full Text] [Related]
15. Chrysin activates Notch1 signaling and suppresses tumor growth of anaplastic thyroid carcinoma in vitro and in vivo. Yu XM; Phan T; Patel PN; Jaskula-Sztul R; Chen H Cancer; 2013 Feb; 119(4):774-81. PubMed ID: 22991264 [TBL] [Abstract][Full Text] [Related]
16. Apatinib Inhibits Angiogenesis Via Suppressing Akt/GSK3β/ANG Signaling Pathway in Anaplastic Thyroid Cancer. Jin Z; Cheng X; Feng H; Kuang J; Yang W; Peng C; Shen B; Qiu W Cell Physiol Biochem; 2017; 44(4):1471-1484. PubMed ID: 29190616 [TBL] [Abstract][Full Text] [Related]
17. The EPRS-ATF4-COLI pathway axis is a potential target for anaplastic thyroid carcinoma therapy. Mi L; Liu J; Zhang Y; Su A; Tang M; Xing Z; He T; Wei T; Li Z; Wu W Phytomedicine; 2024 Jul; 129():155670. PubMed ID: 38704915 [TBL] [Abstract][Full Text] [Related]
18. SOX13/TRIM11/YAP axis promotes the proliferation, migration and chemoresistance of anaplastic thyroid cancer. Tang J; Tian Z; Liao X; Wu G Int J Biol Sci; 2021; 17(2):417-429. PubMed ID: 33613102 [TBL] [Abstract][Full Text] [Related]
19. Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo. Ferrari SM; Bocci G; Di Desidero T; Elia G; Ruffilli I; Ragusa F; Orlandi P; Paparo SR; Patrizio A; Piaggi S; La Motta C; Ulisse S; Baldini E; Materazzi G; Miccoli P; Antonelli A; Fallahi P Oncol Rep; 2018 May; 39(5):2225-2234. PubMed ID: 29517103 [TBL] [Abstract][Full Text] [Related]
20. STAT3 signaling statuses determine the fate of resveratrol-treated anaplastic thyroid cancer cells. Wu J; Li YT; Tian XT; Liu YS; Wu ML; Li PN; Liu J Cancer Biomark; 2020; 27(4):461-469. PubMed ID: 31958078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]